Daniel Ting MD (1st Hons) PhD
Singapore Eye Research Institute
Title. AI and Digital Technology in Ophthalmology
Abstract. The advent of artificial intelligence (AI), big data and next generation tele-communication network (5G) has generated enormous interest in digital health. Digital health comprises overlapping areas ranging from AI, the internet of things (IoT), electronic health and tele-health to the analysis and use of big data. With substantial innovation opportunities in digital health, the World Health Organization (WHO) has published a set of guidelines earlier this year, advising potential researchers and innovators on how to harness this technology to create evidence-based interventions within real-world settings to improve patients’ outcome. This talk aims to highlight some of the new developments in ophthalmology, focusing on AI and other digital innovation, particularly those that are clinically available and could be implemented in the foreseeable futures.
Short bio. Dr Daniel Ting is the Consultant Vitreo-retinal surgeon in the Singapore National Eye Center (SNEC), Head of AI and Digital Innovation in Singapore Eye Research Institute (SERI), Assistant Professor in Ophthalmology with Duke-NUS Medical School Singapore. He is also the visiting Full Professor in Ophthalmology in Zhongshan Ophthalmic Eye Center, Sun Yat-Sen University, China; 2017-2018 US-ASEAN J. W. Fulbright Scholar to Johns Hopkins University, the EXCO of the American Academy Ophthalmology (AAO) AI Task Force and Standards for Reporting of Diagnostic Studies (STARD-AI) Task Force. At present, he is the Associate Editor of Nature Digital Medicine, Section Editor (AI and big data) in British Journal of Ophthalmology (BJO) and the Editor of Ophthalmology, Ophthalmology Retina, Ophthalmology Science and Asia-pacific Journal of Ophthalmology.
To date, he has published >180 peer-reviewed papers/book chapters/conference abstracts, including >40 AI and digital technology articles in JAMA, NEJM, Nature Medicine, Nature Biomedical Engineering, Nature Digital Medicine, Lancet Digital Health, Progress in Retinal and Eye Research, Ophthalmology and etc. Apart from being the invited chair and moderator in many regional and international ophthalmology conferences, he was also invited as the guest speaker at many prestigious universities (e.g., Trinity College at Cambridge, Oxford University, Johns Hopkins University, Seoul National University, Taiwan National University and etc). He holds several patents in deep learning systems for medical imaging analysis, one of which has received approval from the Singapore Health Service Authority (HSA), and European CE Mark. He is also the co-founder of an AI spin-off company, EyRIS Pte Ltd, that has partnered with >20 optometry practices of Singapore Optometry Association thus far.
Dr Ting has won many prestigious scientific awards, including the ARVO Bert Glaser Award for Innovative Research in Retina (2020), USA Macula Society Evangelos Gragoudas Award (2019), Asia-Pacific Academy of Ophthalmology (APAO) Young Ophthalmologist’s Award (2018), the Asia-Pacific Tele-Ophthalmology Society (APTOS) Young Innovator Award (2017), SingHealth Distinguished Young Researcher Award (2018), and Singapore General Hospital Young Investigator Award (2017). In December 2019, he was also rated as one of the 4 thought leaders by The Ophthalmologist, one of the top London-based eye magazines, in the deep learning fields for ophthalmology. His current research interest spans across AI, big data analytics, Internet of Things, Blockchain and AI chatbot using natural language processing and speech recognition.